Next-Generation Antimicrobial Peptides for Biofilm-Associated Infections: Engineering, Biomaterial Delivery and AI-Assisted Discovery
Antibiotics · 08.09.2026 · 15 (9) · 880
DOI: 10.3390/antibiotics15090880 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 08.09.2026. Verfasst von Aghilas Akkache und 2 weiteren Autor:innen. Beteiligte Einrichtung: SPARTHA Medical, Centre de Recherche en Biomédecine de Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) are increasingly regarded as next-generation antimicrobial agents because of their broad-spectrum activity, rapid killing, antibiofilm potential, immunomodulatory properties, and mechanisms of action that differ from those of many conventional antibiotics. Despite these advantages, their clinical translation remains limited by proteolytic instability, hemolysis or cytotoxicity, poor pharmacokinetics, salt and serum sensitivity, production costs, and delivery challenges. The AMP field is therefore shifting from natural peptide discovery toward integrated engineering pipelines that combine rational peptide modification, biomaterial-based delivery, high-throughput screening, and artificial intelligence (AI), particularly machine learning (ML) and deep learning approaches. Chemical and structural modifications, including D-amino acid substitution, N-glycine substitution, cyclization, lipidation, PEGylation, terminal amidation, hydrocarbon stapling, hybridization, sequence truncation, metal coordination, and biomaterial immobilization, are being used to improve stability, potency, selectivity, antibiofilm activity, and tissue localization. In parallel, AI-guided approaches, including ML, deep learning, and generative modeling, enable large-scale exploration of diverse peptide sources, including microbiomes and extinct proteomes, to entirely new sequences, while supporting optimization of potency, selectivity, stability, toxicity, and synthesizability. This focused review summarizes recent advances in AMP engineering, biomaterial-assisted delivery, and AI-guided discovery for biofilm-associated infections in the context of antimicrobial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SPARTHA Medical, Centre de Recherche en Biomédecine de Strasbourg, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
ORCID-Profile: Mattéo Védère, Skander Hathroubi
Zitieren
APA
Akkache, A., Védère, M., & Hathroubi, S. (2026). Next-Generation Antimicrobial Peptides for Biofilm-Associated Infections: Engineering, Biomaterial Delivery and AI-Assisted Discovery. Antibiotics, 15(9), 880. https://doi.org/10.3390/antibiotics15090880
Vancouver
Akkache A, Védère M, Hathroubi S. Next-Generation Antimicrobial Peptides for Biofilm-Associated Infections: Engineering, Biomaterial Delivery and AI-Assisted Discovery. Antibiotics. 2026;15(9):880. doi:10.3390/antibiotics15090880
BibTeX
@article{Akkache2026,
author = {Akkache, Aghilas and Védère, Mattéo and Hathroubi, Skander},
title = {Next-Generation Antimicrobial Peptides for Biofilm-Associated Infections: Engineering, Biomaterial Delivery and AI-Assisted Discovery},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {9},
pages = {880},
doi = {10.3390/antibiotics15090880}
}
EUVIMED